Daniil Gataulin
Stock Analyst at Chardan Capital
(2.03)
# 2,870
Out of 4,843 analysts
92
Total ratings
35.29%
Success rate
-5.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QURE uniQure | Maintains: Buy | $38 | $14.47 | +162.61% | 4 | May 30, 2025 | |
| ADVM Adverum Biotechnologies | Maintains: Buy | $33 | $2.22 | +1,389.84% | 7 | May 15, 2025 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $38 → $35 | $5.13 | +582.93% | 4 | May 14, 2025 | |
| CRVO CervoMed | Maintains: Buy | $14 → $15 | $7.22 | +107.76% | 6 | May 12, 2025 | |
| OCGN Ocugen | Maintains: Buy | $7 | $0.84 | +737.22% | 11 | May 12, 2025 | |
| OCS Oculis Holding AG | Maintains: Buy | $28 → $33 | $19.39 | +70.19% | 7 | May 9, 2025 | |
| EYPT EyePoint Pharmaceuticals | Maintains: Buy | $33 → $27 | $7.24 | +272.93% | 11 | May 8, 2025 | |
| CGTX Cognition Therapeutics | Maintains: Buy | $8 → $4 | $0.24 | +1,573.64% | 7 | May 8, 2025 | |
| TRML Tourmaline Bio | Maintains: Buy | $70 | $16.68 | +319.66% | 2 | May 5, 2025 | |
| UBX Unity Biotechnology | Maintains: Buy | $4 | $0.70 | +472.00% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $61 | $8.50 | +617.65% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $0.76 | +688.44% | 4 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 | $8.84 | +488.24% | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 | $1.84 | +63.04% | 8 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $2.60 | +8,361.54% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.41 | - | 2 | Jul 25, 2023 |
uniQure
May 30, 2025
Maintains: Buy
Price Target: $38
Current: $14.47
Upside: +162.61%
Adverum Biotechnologies
May 15, 2025
Maintains: Buy
Price Target: $33
Current: $2.22
Upside: +1,389.84%
MeiraGTx Holdings
May 14, 2025
Maintains: Buy
Price Target: $38 → $35
Current: $5.13
Upside: +582.93%
CervoMed
May 12, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $7.22
Upside: +107.76%
Ocugen
May 12, 2025
Maintains: Buy
Price Target: $7
Current: $0.84
Upside: +737.22%
Oculis Holding AG
May 9, 2025
Maintains: Buy
Price Target: $28 → $33
Current: $19.39
Upside: +70.19%
EyePoint Pharmaceuticals
May 8, 2025
Maintains: Buy
Price Target: $33 → $27
Current: $7.24
Upside: +272.93%
Cognition Therapeutics
May 8, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $0.24
Upside: +1,573.64%
Tourmaline Bio
May 5, 2025
Maintains: Buy
Price Target: $70
Current: $16.68
Upside: +319.66%
Unity Biotechnology
Apr 23, 2025
Maintains: Buy
Price Target: $4
Current: $0.70
Upside: +472.00%
Apr 1, 2025
Maintains: Buy
Price Target: $64 → $61
Current: $8.50
Upside: +617.65%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $0.76
Upside: +688.44%
Mar 20, 2025
Maintains: Buy
Price Target: $52
Current: $8.84
Upside: +488.24%
Feb 18, 2025
Maintains: Neutral
Price Target: $3
Current: $1.84
Upside: +63.04%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $2.60
Upside: +8,361.54%
Jul 25, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.41
Upside: -